NorthCrest Asset Manangement’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Sell
1,121
-139
-11% -$51.5K 0.01% 583
2026
Q1
$379K Sell
1,260
-24
-2% -$7.89K 0.01% 567
2025
Q4
$467K Sell
1,284
-181
-12% -$61.2K 0.01% 557
2025
Q3
$524K Sell
1,465
-32,854
-96% -$10.2M 0.01% 481
2025
Q2
$11.9M Buy
34,319
+465
+1% +$187K 0.32% 86
2025
Q1
$14.7M Buy
33,854
+818
+2% +$328K 0.44% 71
2024
Q4
$12.2M Buy
33,036
+787
+2% +$329K 0.36% 81
2024
Q3
$16.8M Buy
32,249
+355
+1% +$190K 0.51% 63
2024
Q2
$17.3M Buy
31,894
+199
+0.6% +$105K 0.57% 49
2024
Q1
$16.4M Sell
31,695
-6,569
-17% -$3.27M 0.56% 55
2023
Q4
$18M Buy
38,264
+677
+2% +$313K 0.68% 39
2023
Q3
$16.4M Buy
37,587
+88
+0.2% +$39.9K 0.67% 43
2023
Q2
$16.7M Sell
37,499
-200
-0.5% -$92.3K 0.66% 45
2023
Q1
$17.3M Buy
37,699
+1,651
+5% +$786K 0.72% 40
2022
Q4
$18.5M Buy
36,048
+1,610
+5% +$817K 1.05% 25
2022
Q3
$15.6M Buy
34,438
+1,192
+4% +$570K 0.85% 30
2022
Q2
$16M Sell
33,246
-10,756
-24% -$5.32M 0.82% 35
2022
Q1
$21.6M Buy
+44,002
New +$20.1M 1.03% 20

Other funds holding ELV

NorthCrest Asset Manangement's ELV Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Elevance Health (ELV) stake by 11% in Q2 2026, selling an estimated $51.5K and leaving 1,121 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #583.

NorthCrest Asset Manangement first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $21.6M in Q1 2022. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • NorthCrest Asset Manangement held 1,121 shares of Elevance Health worth $471K as of Q2 2026.
  • NorthCrest Asset Manangement sold 139 Elevance Health shares in Q2 2026, an estimated $51.5K.
  • Elevance Health made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #583 holding.
  • NorthCrest Asset Manangement first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
  • NorthCrest Asset Manangement's Elevance Health position peaked at $21.6M in Q1 2022.
  • 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.